JP2009179639A5 - - Google Patents

Download PDF

Info

Publication number
JP2009179639A5
JP2009179639A5 JP2009120362A JP2009120362A JP2009179639A5 JP 2009179639 A5 JP2009179639 A5 JP 2009179639A5 JP 2009120362 A JP2009120362 A JP 2009120362A JP 2009120362 A JP2009120362 A JP 2009120362A JP 2009179639 A5 JP2009179639 A5 JP 2009179639A5
Authority
JP
Japan
Prior art keywords
dissolved
water
less
protonated compound
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009120362A
Other languages
English (en)
Japanese (ja)
Other versions
JP5503900B2 (ja
JP2009179639A (ja
Filing date
Publication date
Priority claimed from US09/847,654 external-priority patent/US20020032164A1/en
Application filed filed Critical
Publication of JP2009179639A publication Critical patent/JP2009179639A/ja
Publication of JP2009179639A5 publication Critical patent/JP2009179639A5/ja
Application granted granted Critical
Publication of JP5503900B2 publication Critical patent/JP5503900B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2009120362A 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法 Expired - Fee Related JP5503900B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/847,654 2001-05-03
US09/847,654 US20020032164A1 (en) 1998-12-30 2001-05-03 Antimicrobial compounds and methods for their use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002586732A Division JP4347573B2 (ja) 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013210031A Division JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2009179639A JP2009179639A (ja) 2009-08-13
JP2009179639A5 true JP2009179639A5 (enExample) 2009-10-15
JP5503900B2 JP5503900B2 (ja) 2014-05-28

Family

ID=25301163

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2002586732A Expired - Fee Related JP4347573B2 (ja) 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物
JP2009120362A Expired - Fee Related JP5503900B2 (ja) 2001-05-03 2009-05-18 抗菌化合物およびそれらの使用方法
JP2013210031A Expired - Fee Related JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法
JP2015219286A Expired - Fee Related JP6097372B2 (ja) 2001-05-03 2015-11-09 抗菌化合物およびそれらの使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002586732A Expired - Fee Related JP4347573B2 (ja) 2001-05-03 2002-05-03 抗菌組成物、細菌感染症を治療するための方法、及び消毒用組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013210031A Expired - Fee Related JP5883838B2 (ja) 2001-05-03 2013-10-07 抗菌化合物およびそれらの使用方法
JP2015219286A Expired - Fee Related JP6097372B2 (ja) 2001-05-03 2015-11-09 抗菌化合物およびそれらの使用方法

Country Status (10)

Country Link
US (2) US20020032164A1 (enExample)
EP (2) EP2311466B1 (enExample)
JP (4) JP4347573B2 (enExample)
AU (1) AU2002305336B2 (enExample)
CA (2) CA2445381C (enExample)
CY (1) CY1116784T1 (enExample)
DK (1) DK2311466T3 (enExample)
ES (1) ES2549766T3 (enExample)
PT (1) PT2311466E (enExample)
WO (1) WO2002089581A1 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627215B1 (en) * 1998-12-30 2003-09-30 Oligos Etc. Inc. Devices for improved wound management
US7868162B2 (en) * 1998-12-30 2011-01-11 Lakewood-Amedex, Inc. Antimicrobial and antiviral compounds and methods for their use
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
WO2003006478A1 (en) * 2001-07-10 2003-01-23 Oligos Etc. Inc. Oligonucleotide-containing pharmacological compositions and their use
RS53365B (sr) * 2003-08-01 2014-10-31 Mitsubishi Tanabe Pharma Corporation Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavisan od natrijuma
US8785403B2 (en) 2003-08-01 2014-07-22 Mitsubishi Tanabe Pharma Corporation Glucopyranoside compound
RS20060320A (sr) * 2003-08-01 2008-08-07 Janssen Pharmaceutica N.V., Supstituisani indazol-o-glukozidi
TW200727785A (en) * 2005-11-25 2007-08-01 Maruishi Pharma Gel composition for antibacterial sterilization
UY30730A1 (es) * 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
US20100196504A1 (en) * 2007-05-04 2010-08-05 Symrise Gmbh & Co. Kg Synergistic active preparations comprising 1,2-decanediol and further antimicrobial active compounds
NO2200606T3 (enExample) * 2007-09-10 2018-03-24
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
GB2460445B (en) * 2008-05-30 2012-07-11 Vernolix Ltd Treatment of ringworm
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
US20110009347A1 (en) 2009-07-08 2011-01-13 Yin Liang Combination therapy for the treatment of diabetes
JP5658751B2 (ja) 2009-07-10 2015-01-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプJanssen Pharmaceutica Naamloze Vennootschap 1−(β−D−グルコピラノシル)−4−メチル−3−[5−(4−フルオロフェニル)−2−チエニルメチル]ベンゼンのための結晶化方法
PL2488515T3 (pl) * 2009-10-14 2017-07-31 Janssen Pharmaceutica Nv Sposób wytwarzania związków użytecznych jako inhibitory sglt2
LT2568988T (lt) 2010-05-11 2016-09-12 Janssen Pharmaceutica, N.V. Farmacinės kompozicijos, apimančios 1-(beta-d-gliukopiranozil)-2-tienilmetilbenzeno darinius kaip sglt inhibitorius
KR101913587B1 (ko) 2011-04-13 2018-10-31 얀센 파마슈티카 엔.브이. Sglt2의 억제제로서 유용한 화합물의 제조 방법
TWI542596B (zh) 2011-05-09 2016-07-21 健生藥品公司 (2s,3r,4r,5s,6r)-2-(3-((5-(4-氟苯基)噻吩-2-基)甲基)-4-甲基苯基)-6-(羥甲基)四氫-2h-哌喃-3,4,5-三醇之l-脯胺酸及檸檬酸共晶體
US20170071970A1 (en) 2015-09-15 2017-03-16 Janssen Pharmaceutica Nv Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders
US11795192B2 (en) 2017-03-10 2023-10-24 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
JP6917078B2 (ja) * 2017-03-10 2021-08-11 レイクウッド アメディックス、インコーポレイテッド 抗菌化合物、組成物、及びそれらの使用
US12030908B2 (en) 2017-03-10 2024-07-09 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
US11377468B2 (en) 2017-03-10 2022-07-05 Lakewood Amedex, Inc. Antimicrobial compounds, compositions, and uses thereof
EP3638251B1 (en) 2017-06-12 2024-03-06 Lakewood Amedex, Inc. Bisphosphocin gel formulations and uses thereof
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company Composition and method for improving the appearance of skin
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
BR112021006954A2 (pt) 2018-10-17 2021-07-20 Lakewood Amedex, Inc. métodos e composições para tratar mucosite oral
CZ308943B6 (cs) * 2019-12-12 2021-09-22 Ústav organické chemie a biochemie AV ČR, v. v. i. Lipofosfonoxiny třetí generace, jejich příprava a použití
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンb3化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
KR20220009630A (ko) * 2020-07-16 2022-01-25 정준영 플라즈마를 이용한 마스크 폐기 처리기
CN115448967A (zh) * 2022-09-26 2022-12-09 泽同医药科技(南通)有限公司 一种吩噁嗪半乳烯糖碳苷化合物及其合成方法
WO2025179296A1 (en) * 2024-02-22 2025-08-28 Lakewood Amedex, Inc. Crystalline forms of nu-3 and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105782A (en) 1975-03-07 1978-08-08 Yu Ruey J Treatment of acne and dandruff
DE2916318A1 (de) * 1979-04-23 1980-11-06 Hoechst Ag Waesserige desinfektionsloesung
US4421769A (en) 1981-09-29 1983-12-20 The Procter & Gamble Company Skin conditioning composition
US4908209A (en) * 1983-08-16 1990-03-13 Interface, Inc. Biocidal delivery system of phosphate ester and method of preparation thereof
JPS60209077A (ja) * 1984-03-27 1985-10-21 竹本油脂株式会社 繊維処理用油剤及び該油剤による合成繊維糸の処理方法
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
DE3542516A1 (de) 1985-12-02 1987-06-04 Henkel Kgaa Desinfektionsmittel
JPH02504401A (ja) * 1987-08-03 1990-12-13 インターフェイス リサーチ コーポレイション 殺微生物性洗浄処方物または消毒処方物およびその製造方法
US5153000A (en) * 1988-11-22 1992-10-06 Kao Corporation Phosphate, liposome comprising the phosphate as membrane constituent, and cosmetic and liposome preparation comprising the liposome
ZA902710B (en) 1989-05-22 1991-12-24 Univ Georgia Res Found Enzyme luminescence assay
US5153230A (en) 1989-10-06 1992-10-06 Perfective Cosmetics, Inc. Topical skin cream composition
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US5420330A (en) * 1990-09-07 1995-05-30 Pharmacia P-L Biochemicals Inc. Lipo-phosphoramidites
AU9097791A (en) * 1990-12-07 1992-07-08 Upjohn Company, The Phosphonic acid derivatives useful as antiinflammatory agents
US5811568A (en) * 1992-10-08 1998-09-22 Shaman Pharmaceuticals, Inc. Process for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activity
CA2146639A1 (en) * 1992-10-08 1994-04-28 Michael Tempesta Novel class of phosphocholine derivatives having antifungal activity
US5681829A (en) * 1992-10-08 1997-10-28 Shaman Pharmaceuticals, Inc. Class of phosphocholine derivatives having antifungal activity
DE4333385C2 (de) 1993-09-30 1997-01-30 Friedrich A Spruegel Flächendesinfektions- und Reinigungsmittel
FR2718022B1 (fr) 1994-04-01 1996-04-26 Roussel Uclaf Compositions cosmétiques ou dermatologiques et leur préparation.
FR2727289B1 (fr) * 1994-11-30 1999-03-05 Derives Resiniques Terpenique Composition desinfectante comprenant au moins un alcool terpenique et au moins un tensio-actif acide bactericide, et utilisation de tels tensio-actifs
JP2001509779A (ja) * 1995-11-28 2001-07-24 デー. ワイダー,マイケル 抗菌組成物とその使用方法
US5843998A (en) 1997-06-30 1998-12-01 Song; Jin Skin blemish treatment
US20020032164A1 (en) * 1998-12-30 2002-03-14 Dale Roderic M. K. Antimicrobial compounds and methods for their use
US6211349B1 (en) * 1998-12-30 2001-04-03 Oligos Etc., Inc. Protonated/acidified nucleic acids and methods of use
US6610314B2 (en) * 2001-03-12 2003-08-26 Kimberly-Clark Worldwide, Inc. Antimicrobial formulations

Similar Documents

Publication Publication Date Title
JP2009179639A5 (enExample)
JP2005511482A5 (enExample)
JP2013540786A5 (enExample)
JP2013503846A5 (enExample)
JP2010515731A5 (enExample)
RU2010126056A (ru) Органические соединения
MA30352B1 (fr) Pyridine [3,4-b] pyrazinones
WO2008100867A3 (en) Novel inhibitors hepatitis c virus replication
JP2010195800A5 (enExample)
JP2010518128A5 (enExample)
JP2010530881A5 (enExample)
JP2011500769A5 (enExample)
EA201071034A1 (ru) Новые макроциклические ингибиторы репликаций вируса гепатита с
JP2009535358A5 (enExample)
MX2009011867A (es) Nuevos inhibidores macrociclicos de la replicacion del virus de hepatitis c.
JP2010500343A5 (enExample)
JP2006524660A5 (enExample)
JP2013543842A5 (enExample)
JP2010530373A5 (enExample)
JP2007302689A5 (enExample)
JP2015512943A5 (enExample)
JP2009520695A5 (enExample)
RU2015122032A (ru) Оксазолидинонсодержащие соединения, композиции и способы их использования
JP2010079247A5 (enExample)
ATE373009T1 (de) Verfahren zur vorbereitung von telithromycin